Patients with Low Drug Levels or Antibodies to a Prior Anti-TNF Are More Likely to Develop Antibodies to a Subsequent Anti-TNF.
暂无分享,去创建一个
M. Silverberg | F. Rieder | S. Flier | M. Abreu | R. Khanna | A. Cheifetz | K. Papamichael | Anjali Jain | N. V. Casteele | L. Okada | Lei Yang